4. 成本效用比（Cost-Utility Ratio, CUR）：CUR是CUA中用来评估医疗干预的成本效益的关键指标，它是总成本除以获得的QALYs。5. 增量成本效用比（Incremental Cost-Utility Ratio, ICUR）：当比较两种或多种医疗干预措施时，使用ICUR来确定哪种干预措施更具成本效益。ICUR是两种干预措施成本差异与QALYs差异的比值。
【答案】：是比较项目投入成本量和经质量调整的健康效益产出量，来衡量卫生项目或治疗措施效率的一种经济学评价方法。其评价指标是成本效用比（costutilityratio，CUR）：表示项目获得每个单位的QALY所消耗或增加的成本量，成本效用比值越高，表示项目效率越低。
Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care. J Am Coll Cardiol. 2002;40(7):1259- 66.Capomolla S, Febo O, Ceresa M, et al. Cost/utility ratio in chronic heart failure: comparison between heart ...
26Managing drug-related problems in advanced heart failure patients Cost/utility ratio in chronic heart failure: Comparison between heart failure management program delivered by day-hospital and usual care. J Am Coll Cardiol... V Lee - 《Heart Asia》 被引量: 0发表: 2018年 What Works In ...
Outcomes such as quality-adjusted life years (QALYs), survival, and costs were calculated and summarized for all modelled patients separately for FCM and FDI. These outcomes were then used to determine an incremental cost-utility ratio (ICUR) and net monetary benefit for FDI versus FCM. The ...
In sensitivity analysis the most important factors influencing the cost-utility ratio in decreasing order were mortality in the year of transfusion, mortality associated with type of blood components received, the number of donor exposures per pooled platelet preparation, the probability ...
The incremental cost-utility ratio (ICUR) will be estimated as the ratio between the costs and QALY differences [46]. The same analysis will be performed at 1, 2, and 5 years to assess the evolution of the treatment. Ethics The Balearic Island Ethical Committee has approved the trial (...
The high cost-utility ratio of NT $3246.45 for pansinusitis cases is due to the higher cost and limited utility gain. Treating mild and moderate chronic sinusitis are most cost-effective because of their favorable utility gain and relatively reasonable cost. However, there is no proportional ...
关键词: cost-effectiveness analysis cost-utility analysis HTA incremental cost-effectiveness ratio incremental cost-utility ratio Poland DOI: 10.1016/j.vhri.2014.06.008 被引量: 15 年份: 2014 收藏 引用 批量引用 报错 分享 全部来源 免费下载 求助全文 Elsevier Semantic Scholar (全网免费下载) dx.doi....
The results of the CUA are presented as the incremental cost-utility ratio (ICUR) which is the ratio of the incremental cost and the incremental QALY. The ICUR stands for the additional cost per QALY gained associated with the new intervention in comparison with treatment as usual or ...